These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2406299)

  • 1. Probucol: pharmacology and clinical application.
    Zimetbaum P; Eder H; Frishman W
    J Clin Pharmacol; 1990 Jan; 30(1):3-9. PubMed ID: 2406299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions.
    Yamamoto A; Hara H; Takaichi S; Wakasugi J; Tomikawa M
    Am J Cardiol; 1988 Jul; 62(3):31B-36B. PubMed ID: 3394651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
    Glueck CJ
    Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
    Tomikawa M; Nakayasu T; Tawara K; Abiko Y
    Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
    Dachet C; Jacotot B; Buxtorf JC
    Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of probucol.
    Steinberg D
    Am J Cardiol; 1986 Jun; 57(16):16H-21H. PubMed ID: 3728306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
    Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol in long-term treatment of hypercholesterolemia.
    Strandberg TE; Vanhanen H; Miettinen TA
    Gen Pharmacol; 1988; 19(3):317-20. PubMed ID: 3046993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnover.
    Lock DR; Kuisk I; Gonen B; Patsch W; Schonfeld G
    Atherosclerosis; 1983 Jun; 47(3):271-8. PubMed ID: 6882500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
    Steinberg D; Parthasarathy S; Carew TE
    Am J Cardiol; 1988 Jul; 62(3):6B-12B. PubMed ID: 3394654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.
    Buckley MM; Goa KL; Price AH; Brogden RN
    Drugs; 1989 Jun; 37(6):761-800. PubMed ID: 2667936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural changes in oxidised low-density lipoproteins and of the effect of the anti-atherosclerotic drug probucol observed by synchrotron X-ray and neutron solution scattering.
    Bellamy MF; Nealis AS; Aitken JW; Bruckdorfer KR; Perkins SJ
    Eur J Biochem; 1989 Aug; 183(2):321-9. PubMed ID: 2759086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Probucol: mechanism of action (author's transl)].
    Infante R
    Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of hypocholesterolemic action of probucol in animals and man.
    Beynen AC
    Artery; 1987; 14(2):113-26. PubMed ID: 3551883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of probucol in man (author's transl)].
    Leutenegger M
    Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat.
    Strandberg T; Kuusi T; Tilvis R; Miettinen TA
    Atherosclerosis; 1981; 40(3-4):193-201. PubMed ID: 7332600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
    Tikkanen MJ; Helve E; Nikkilä EA
    Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.